Skip to search formSkip to main contentSkip to account menu

TAK 044

Known as: TAK-044 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Cyclic Peptides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Effect of combination of endothelin receptor antagonist (TAK-044) and aspirin in middle cerebral artery occlusion model of acute ischemic stroke in rats.
The present study was carried out to investigate the effect of the combination of an endothelin antagonist TAK-044 and an… 
2006
2006
Increased endothelin‐1 levels of BAL fluid in patients with pulmonary sarcoidosis
Objective and background:  Pulmonary fibrosis in sarcoidosis is a significant cause of morbidity and mortality. Various factors… 
2003
2003
The peptide endothelin receptor antagonist, TAK-044, produces sustained inhibition of endothelin-1 mediated arteriolar vasoconstriction.
AIMS Endothelin-1 (ET-1) has been implicated in the pathophysiology of a number of cardiovascular diseases for which endothelin… 
Highly Cited
2000
Highly Cited
2000
An efficacy and safety study of the ETA/B receptor antagonist TAK-044 in subarachnoid hemorrhage
Object. Delayed cerebral ischemia remains an important cause of death and disability in patients who have suffered subarachnoid… 
1999
1999
Combined treatment with endothelin- and PAF-antagonists reduces posttransplant lung ischemia/reperfusion injury.
1999
1999
Endothelin antagonist treatment for successful liver transplantation from non-heart-beating donors.
BACKGROUND With the shortage of cadaveric donors, non-heart-beating donors (NHBDs) are a potential source of liver allografts… 
1998
1998
Renal haemodynamic effects of endothelin‐1 and the ETA/ETB antagonist TAK‐044 in anaesthetized rabbits
Objective The aim of this study was to test the effects of exogenous endothelin-1 (ET-1) on regional kidney blood flow and renal… 
1997
1997
Hepatoprotective effect of a nonselective endothelin receptor antagonist (TAK-044) in the transplanted liver.
This study was designed to investigate whether or not a novel nonselective endothelin A/B (ETA/ETB) receptor antagonist (TAK-044… 
1997
1997
Attenuation of ischemic liver injury by a non-selective endothelin receptor antagonist.
1995
1995
Role of Endogenous Endothelin in the Extension of Myocardial Infarct Size Studied with the Endothelin Receptor Antagonist, TAK‐044
Summary: The effects of TAK-044 on the extension of ischemia/reperfusion-induced myocardial infarction were studied in rats… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)